The Significance of Monoamine Oxidase-A Expression in High Grade Prostate Cancer

Journal of Urology

Volumn 180, Issue 5, 2008, Pages 2206-2211

  Peehl, Donna M ^a   Coram, Marc ^a   Khine, Htet ^a   Reese, Stephen ^a   Nolley, Rosalie ^a   Zhao, Hongjuan ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adenocarcinoma; CD44 protein, human; local; monoamine oxidase; neoplasm recurrence; prostate

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CYTOKERATIN 14; CYTOKERATIN 5; HERMES ANTIGEN; PROSTATE SPECIFIC ANTIGEN; PROTEIN P63;

ADULT; AGED; ARTICLE; BASAL CELL; CANCER GRADING; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, CD44; BIOPSY, NEEDLE; COHORT STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 53249115160     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.07.019     Document Type: Article

References (18)

1. Han M., Partin A.W., Zahurak M., Piantadosi S., Epstein J.I., and Walsh P.C. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169 (2003) 517
2. Stamey T.A., McNeal J.E., Yemoto C.M., Sigal B.M., and Johnstone I.M. Biological determinants of cancer progression in men with prostate cancer. JAMA 281 (1999) 1395
3. True L., Coleman I., Hawley S., Huang C.Y., Gifford D., Coleman R., et al. A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proc Natl Acad Sci U S A 103 (2006) 10991
4. Youdim M.B., Edmondson D., and Tipton K.F. The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7 (2006) 295
5. Zhao H., Nolley R., Chen Z., Reese S.W., and Peehl D.M. Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells. Differentiation 76 (2008) 820
6. Schalken J.A., and van Leenders G. Cellular and molecular biology of the prostate: stem cell biology. Urology 62 (2003) 11
7. Liu A.Y., Roudier M.P., and True L.D. Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile. Am J Pathol 165 (2004) 1543
8. Signoretti S., Waltregny D., Dilks J., Isaac B., Lin D., Garraway L., et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 157 (2000) 1769
9. Oliai B.R., Kahane H., and Epstein J.I. Can basal cells be seen in adenocarcinoma of the prostate?. an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody. Am J Surg Pathol 26 (2002) 1151
10. Chuang A.Y., DeMarzo A.M., Veltri R.W., Sharma R.B., Bieberich C.J., and Epstein J.I. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Am J Surg Pathol 31 (2007) 1246
11. Wang H., Leav I., Ibaragi S., Wegner M., Hu G.F., Lu M.L., et al. SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res 68 (2008) 1625
12. Patrawala L., Calhoun T., Schneider-Broussard R., Li H., Bhatia B., Tang S., et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25 (2006) 1696
13. Pound C.R., Partin A.W., Eisenberger M.A., Chan D.W., Pearson J.D., and Walsh P.C. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591
14. Ekici S., Cerwinka W.H., Duncan R., Gomez P., Civantos F., Soloway M.S., et al. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer. Int J Cancer 112 (2004) 121
15. Aaltomaa S., Lipponen P., Viitanen J., Kankkunen J.P., Ala-Opas M., and Kosma V.M. Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy. Eur Urol 38 (2000) 555
16. Carter H.B., and Isaacs W.B. Improved biomarkers for prostate cancer: a definite need. J Natl Cancer Inst 96 (2004) 813
17. Toninello A., Pietrangeli P., De Marchi U., Salvi M., and Mondovi B. Amine oxidases in apoptosis and cancer. Biochim Biophys Acta 1765 (2006) 1
18. Shih J.C., Chen K., and Ridd M.J. Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22 (1999) 197